ORIC Pharmaceuticals, Inc.
ORIC
$5.26
-$0.52-9.00%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -36.31M | -34.57M | -31.96M | -25.01M | -28.33M |
| Total Depreciation and Amortization | 304.00K | 270.00K | 272.00K | 261.00K | 263.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.57M | 3.11M | 2.70M | 2.73M | 1.81M |
| Change in Net Operating Assets | 4.38M | 2.39M | 3.37M | -8.17M | 1.98M |
| Cash from Operations | -28.05M | -28.80M | -25.63M | -30.19M | -24.27M |
| Capital Expenditure | -219.00K | -418.00K | -333.00K | -218.00K | -57.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 42.87M | 23.49M | 18.61M | -61.65M | 21.02M |
| Cash from Investing | 42.66M | 23.07M | 18.28M | -61.87M | 20.96M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 575.00K | 126.00K | 816.00K | 125.20M | 454.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | -168.00K | -1.00K |
| Cash from Financing | 575.00K | 126.00K | 816.00K | 125.03M | 453.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 15.18M | -5.60M | -6.53M | 32.98M | -2.85M |
